Prenetics Global (PRE) Registration Filing summary

Company overview and business model

• Focuses on consumer health, longevity, and preventive wellness, leveraging scientific expertise and digital asset innovation.

• Operates premium supplement brand IM8 Health, genetic testing brand CircleDNA, and holds a 35% stake in early cancer detection company Insighta.

• Acquired Europa Sports Partners to expand U.S. distribution and divested ACT Genomics to streamline operations.

• Implements a Bitcoin treasury strategy, integrating digital assets into its healthcare ecosystem and accepting cryptocurrency payments.

Financial performance and metrics

• IM8 Health achieved over $60 million annual recurring revenue (ARR) within six months of launch, targeting $100 million ARR by year-end.

• As of June 30, 2025, consolidated current assets were approximately $44 million, including $17 million in cash and $20 million in Bitcoin (classified as non-current intangible assets).

• Completed a $20 million Bitcoin purchase in June 2025, holding 187.42 BTC at an average price of $106,712 per Bitcoin.

Use of proceeds and capital allocation

• Net proceeds from securities offerings may be used to acquire Bitcoin and for general corporate purposes, with management retaining broad discretion over allocation.

• Board-approved strategy to allocate up to 80% of available cash (excluding operational needs) to Bitcoin, maintaining at least 24 months of operational cash reserves.